165 related articles for article (PubMed ID: 33895694)
1. Synthesis, characterization and multiple targeting with selectivity: Anticancer property of ternary metal phenanthroline-maltol complexes.
Ng CH; Tan TH; Tioh NH; Seng HL; Ahmad M; Ng SW; Gan WK; Low ML; Lai JW; Zulkefeli M
J Inorg Biochem; 2021 Jul; 220():111453. PubMed ID: 33895694
[TBL] [Abstract][Full Text] [Related]
2. Efficient hydrolytic cleavage of DNA and antiproliferative effect on human cancer cells by two dinuclear Cu(II) complexes containing a carbohydrazone ligand and 1,10-phenanthroline as a coligand.
Parsekar SU; Singh M; Mishra DP; Antharjanam PKS; Koley AP; Kumar M
J Biol Inorg Chem; 2019 May; 24(3):343-363. PubMed ID: 30887122
[TBL] [Abstract][Full Text] [Related]
3. Exploring the cytotoxic activity of new phenanthroline salicylaldimine Zn(II) complexes.
Matos CP; Addis Y; Nunes P; Barroso S; Alho I; Martins M; Matos APA; Marques F; Cavaco I; Costa Pessoa J; Correia I
J Inorg Biochem; 2019 Sep; 198():110727. PubMed ID: 31195153
[TBL] [Abstract][Full Text] [Related]
4. Redox-cycling and intercalating properties of novel mixed copper(II) complexes with non-steroidal anti-inflammatory drugs tolfenamic, mefenamic and flufenamic acids and phenanthroline functionality: Structure, SOD-mimetic activity, interaction with albumin, DNA damage study and anticancer activity.
Simunkova M; Lauro P; Jomova K; Hudecova L; Danko M; Alwasel S; Alhazza IM; Rajcaniova S; Kozovska Z; Kucerova L; Moncol J; Svorc L; Valko M
J Inorg Biochem; 2019 May; 194():97-113. PubMed ID: 30849593
[TBL] [Abstract][Full Text] [Related]
5. May iron(III) complexes containing phenanthroline derivatives as ligands be prospective anticancer agents?
Matos CP; Adiguzel Z; Yildizhan Y; Cevatemre B; Onder TB; Cevik O; Nunes P; Ferreira LP; Carvalho MD; Campos DL; Pavan FR; Pessoa JC; Garcia MH; Tomaz AI; Correia I; Acilan C
Eur J Med Chem; 2019 Aug; 176():492-512. PubMed ID: 31132480
[TBL] [Abstract][Full Text] [Related]
6. 1,10-Phenanthroline promotes copper complexes into tumor cells and induces apoptosis by inhibiting the proteasome activity.
Zhang Z; Bi C; Schmitt SM; Fan Y; Dong L; Zuo J; Dou QP
J Biol Inorg Chem; 2012 Dec; 17(8):1257-67. PubMed ID: 23053530
[TBL] [Abstract][Full Text] [Related]
7. Ruthenium(II) Phosphine/Mercapto Complexes: Their in Vitro Cytotoxicity Evaluation and Actions as Inhibitors of Topoisomerase and Proteasome Acting as Possible Triggers of Cell Death Induction.
Ribeiro GH; Guedes APM; de Oliveira TD; de Correia CRSTB; Colina-Vegas L; Lima MA; Nóbrega JA; Cominetti MR; Rocha FV; Ferreira AG; Castellano EE; Teixeira FR; Batista AA
Inorg Chem; 2020 Oct; 59(20):15004-15018. PubMed ID: 32997499
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic and apoptotic effects of ternary silver(i) complexes bearing 2-formylpyridine thiosemicarbazones and 1,10-phenanthroline.
Silva DES; Becceneri AB; Solcia MC; Santiago JVB; Moreira MB; Gomes Neto JA; Pavan FR; Cominetti MR; Pereira JCM; Netto AVG
Dalton Trans; 2020 Apr; 49(16):5264-5275. PubMed ID: 32242564
[TBL] [Abstract][Full Text] [Related]
9. [Zn(phen)(O,N,O)(H2O)] and [Zn(phen)(O,N)(H2O)] with O,N,O is 2,6-dipicolinate and N,O is L-threoninate: synthesis, characterization, and biomedical properties.
Chin LF; Kong SM; Seng HL; Tiong YL; Neo KE; Maah MJ; Khoo AS; Ahmad M; Hor TS; Lee HB; San SL; Chye SM; Ng CH
J Biol Inorg Chem; 2012 Oct; 17(7):1093-105. PubMed ID: 22825726
[TBL] [Abstract][Full Text] [Related]
10. Selective anticancer copper(II)-mixed ligand complexes: targeting of ROS and proteasomes.
Ng CH; Kong SM; Tiong YL; Maah MJ; Sukram N; Ahmad M; Khoo AS
Metallomics; 2014 Apr; 6(4):892-906. PubMed ID: 24549332
[TBL] [Abstract][Full Text] [Related]
11. Two isostructural Co(II) flufenamato and niflumato complexes with bathocuproine: Analogues with a different cytotoxic activity.
Smolko L; Smolková R; Samoľová E; Morgan I; Saoud M; Kaluđerović GN
J Inorg Biochem; 2020 Sep; 210():111160. PubMed ID: 32717439
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, structural characterization and cytotoxic activity of ternary copper(II)-dipeptide-phenanthroline complexes. A step towards the development of new copper compounds for the treatment of cancer.
Iglesias S; Alvarez N; Torre MH; Kremer E; Ellena J; Ribeiro RR; Barroso RP; Costa-Filho AJ; Kramer MG; Facchin G
J Inorg Biochem; 2014 Oct; 139():117-23. PubMed ID: 25033418
[TBL] [Abstract][Full Text] [Related]
13. Ruthenium(II) salicylate complexes inducing ROS-mediated apoptosis by targeting thioredoxin reductase.
Chen JC; Zhang Y; Jie XM; She J; Dongye GZ; Zhong Y; Deng YY; Wang J; Guo BY; Chen LM
J Inorg Biochem; 2019 Apr; 193():112-123. PubMed ID: 30711557
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic studies of in vitro anti-proliferative and anti-inflammatory activities of the Zn(ii)-NSAID complexes of 1,10-phenanthroline-5,6-dione in MDA-MB-231 cells.
Deb J; Lakshman TR; Ghosh I; Jana SS; Paine TK
Dalton Trans; 2020 Aug; 49(32):11375-11384. PubMed ID: 32766641
[TBL] [Abstract][Full Text] [Related]
15. Thiosemicarbazone Cu(II) and Zn(II) complexes as potential anticancer agents: syntheses, crystal structure, DNA cleavage, cytotoxicity and apoptosis induction activity.
Shao J; Ma ZY; Li A; Liu YH; Xie CZ; Qiang ZY; Xu JY
J Inorg Biochem; 2014 Jul; 136():13-23. PubMed ID: 24690556
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, X-ray crystal structure, DNA/BSA binding, DNA cleavage and cytotoxicity studies of phenanthroline based copper(II)/zinc(II) complexes.
Wang Q; Mao H; Wang W; Zhu H; Dai L; Chen Y; Tang X
Biometals; 2017 Aug; 30(4):575-587. PubMed ID: 28616784
[TBL] [Abstract][Full Text] [Related]
17. Lysosome-targeted ruthenium(II) complexes induce both apoptosis and autophagy in HeLa cells.
Pan NL; Liao JX; Huang MY; Zhang YQ; Chen JX; Zhang ZW; Yang ZX; Long XE; Wu XT; Sun J
J Inorg Biochem; 2022 Apr; 229():111729. PubMed ID: 35066350
[TBL] [Abstract][Full Text] [Related]
18. Mixed ligand copper(II) complexes of N,N-bis(benzimidazol-2-ylmethyl)amine (BBA) with diimine co-ligands: efficient chemical nuclease and protease activities and cytotoxicity.
Loganathan R; Ramakrishnan S; Suresh E; Riyasdeen A; Akbarsha MA; Palaniandavar M
Inorg Chem; 2012 May; 51(10):5512-32. PubMed ID: 22559171
[TBL] [Abstract][Full Text] [Related]
19. Dinuclear platinum(II) complexes of imidazophenanthroline-based bridging ligands as potential anticancer agents: synthesis, characterization, and in vitro cytotoxicity studies.
Alexander C; Prajith NU; Priyanka PV; Nithyakumar A; Arockia Samy N
J Biol Inorg Chem; 2019 May; 24(3):405-418. PubMed ID: 30945024
[TBL] [Abstract][Full Text] [Related]
20. Enantiomeric pairs of ternary copper(ii) complexes and their aldol-type condensation products: synthesis, characterization, and anticancer and epigenetic properties.
Lee KY; Ng YL; Wang WS; Ng PY; Chan CW; Lai JW; Davamani F; Chitra E; Lim WM; Ganguly R; Maah MJ; Yip FW; Ng CH
Dalton Trans; 2019 Apr; 48(15):4987-4999. PubMed ID: 30916098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
